Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
As per available reports about 2 Relevant Journals, 42 Conferences, 29 Workshops are presently dedicated exclusively to Biopharmaceutics and about 2,070 articles are being published on Biopharmaceutics.
Biopharmaceutics is the study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action, including co-constituents and mode of manufacture. A biopharmaceutical, also known as a biologic medical product or biologic, is any medicinal product manufactured in, extracted from, or semi-synthesized from biological sources. Different from chemically synthesized pharmaceuticals, they include vaccines, blood, or blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They are isolated from natural sources—human, animal, or microorganism. The following aspects include: Novel Approaches in Biopharmaceutics, Clinical Trials in Biopharmaceutics, Drug Elimination & Clearance.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Their rapid development arises from the ability to overcome the drawbacks of the currently employed therapeutic drugs, which exhibit poor biopharmaceutical and pharmacokinetic properties. Nanoparticle drug carriers provide alternative formulation strategies for those molecules thus enhancing the scope for commercialization. They are potential for prolonged drug release. The conference too offers growth to expand reserves of knowledge and explore newer realms.
Biopharmaceutics is the study which shows how the drug absorption rate is affected by various factors like physical and chemical properties of the drug, the dose form of the drug and the route through which the drug is administered.
It includes the study of the following
“Pharmacokinetics is defined as the study of rate processes involved in absorption, distribution, metabolism and excretion" It will decide the how much drug should to be given to the patient, and the route through which the drug must be administered, the time taken by the drug to start its action, and how long the drug action will remain. Absorption is the movement of the drug into the systemic circulation from where the drug has been delivered. Once it’s absorbed it will move to the other parts of the body which is called distribution. Metabolism is the phenomenon of the chemical changes that drug undergo within the body. Excretion is the moving out of the drug from the body.
The global market for biopharmaceuticals was estimated at US$200 billion in 2013, and we currently have more than 10,000 therapeutics under development. The market is already the fastest growing sector of the pharmaceutical industry and has been predicted to reach US$497.9 billion by 2020.
International Symposium and Workshops
Relevant Society and Associations:
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising